Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03470194 · ClinicalTrials.gov registry record · NA

Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial

A NA study of Pelvic Floor Disorders, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT03470194: Completed NA study of Pelvic Floor Disorders, sponsored by University of Massachusetts, Worcester.

NCT03470194 is a NA study of Pelvic Floor Disorders that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 106 participants, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03470194, a NA study of Pelvic Floor Disorders, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to determine if In-person interpreters increases patient satisfaction of URGYN office visits compared to the use of phone interpreter services for Limited English Proficient (LEP) patients

Primary Outcome

Patient satisfaction will be measured by a 14 - item questionnaire. The questionnaire was created, validated, and used in a previous study from the field of Emergency medicine. There are 3 subscales assessing patient satisfaction with interpreter, nursing, and physician. Satisfaction with interpreters was calculated using the summation index of 4 items. Satisfaction with physician and nursing communication was measure by a summated index of 5 items that measure increasing level of satisfaction w

Conditions Studied

Interventions

  • OTHER Interpretation Modality: In Person
  • OTHER Interpretation Modality: Telephonic

Study Locations (1)

Massachusetts

  • U Mass Memorial Hospital - Worcester

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2017-12-15
Est. Completion 2019-06-15
Phase NA

What the finished NCT03470194 record still lists

NCT03470194 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target.

The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 2 interventions - of which Interpretation Modality: In Person is the first listed.

NCT03470194 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03470194 about?

NCT03470194 is a clinical study titled "Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial". The aim of the study is to determine if In-person interpreters increases patient satisfaction of URGYN office visits compared to the use of phone interpreter services for Limited English Proficient (LEP) patients

What is the current status of trial NCT03470194?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2017-12-15. Estimated completion is 2019-06-15.

What conditions does trial NCT03470194 study?

This clinical trial studies the following conditions: Pelvic Floor Disorders.

What interventions are being tested in trial NCT03470194?

The interventions under investigation include: Interpretation Modality: In Person (OTHER), Interpretation Modality: Telephonic (OTHER).

Who is sponsoring clinical trial NCT03470194?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03470194 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Floor Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03470194's enrollment target sits among peer trials

106 5th of 11 higher than 7 of 11 other Pelvic Floor Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Floor Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03470194, the US trial registry maintained by the National Library of Medicine. NCT03470194 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.